pentobarbital will reduce the extent or outcome of cinacalcet by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will decrease the extent or effect of hydrocortisone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

Contraindicated. Coadministration of doravirine with a powerful CYP3A inducer might reduce doravirine plasma concentrations and/or effects. Prospective for loss of virologic reaction and doable resistance to doravirine.

Parenteral alternatives of barbiturates are hugely alkaline; Intense treatment need to be taken to stay away from perivascular extravasation or intra-arterial injection; extravascular injection may possibly trigger community tissue harm with subsequent necrosis; penalties of intra-arterial injection may possibly differ from transient discomfort to gangrene on the limb; any criticism of ache during the limb warrants stopping the injection

pentobarbital will lessen the extent or effect of ixabepilone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

Induction of microsomal enzymes by this drug, may well shorten the 50 percent-lifetime of doxycycline for so long as 2 weeks right after barbiturate therapy discontinued; keep an eye on scientific reaction to doxycycline closely if each drugs administered concurrently

buprenorphine, prolonged-acting injection and pentobarbital both equally enhance sedation. Stay away from or Use Alternate Drug. Limit use to sufferers for whom substitute procedure solutions are insufficient

pentobarbital will reduce the extent or impact of aprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will lessen the level or impact of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will minimize the extent or influence of vincristine by impacting hepatic/intestinal enzyme CYP3A4 click here metabolism. Slight/Significance Unknown.

과량일시, 펜토바르비탈은 호흡기를 억제시켜 죽음에 이르게 한다. 미국에서, 펜토바르비탈은 사형에 사용된다.

pentobarbital will lower the level or impact of vincristine liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.

pentobarbital will minimize the extent or influence of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Check sufferers by now on buprenorphine subdermal implant who require freshly-initiated treatment with CYP3A4 inducer for signs and signs of withdrawal.

pentobarbital decreases levels of vandetanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Prevent coadministration with potent CYP3A4 inducers; these drugs minimize exposure to vandetanib by around 40%.